These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 19435837)
1. Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds. De Preter K; De Brouwer S; Van Maerken T; Pattyn F; Schramm A; Eggert A; Vandesompele J; Speleman F Clin Cancer Res; 2009 Jun; 15(11):3690-6. PubMed ID: 19435837 [TBL] [Abstract][Full Text] [Related]
2. ArrayCGH-based classification of neuroblastoma into genomic subgroups. Michels E; Vandesompele J; De Preter K; Hoebeeck J; Vermeulen J; Schramm A; Molenaar JJ; Menten B; Marques B; Stallings RL; Combaret V; Devalck C; De Paepe A; Versteeg R; Eggert A; Laureys G; Van Roy N; Speleman F Genes Chromosomes Cancer; 2007 Dec; 46(12):1098-108. PubMed ID: 17823929 [TBL] [Abstract][Full Text] [Related]
3. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085 [TBL] [Abstract][Full Text] [Related]
4. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. De Preter K; Vandesompele J; Heimann P; Yigit N; Beckman S; Schramm A; Eggert A; Stallings RL; Benoit Y; Renard M; De Paepe A; Laureys G; Påhlman S; Speleman F Genome Biol; 2006; 7(9):R84. PubMed ID: 16989664 [TBL] [Abstract][Full Text] [Related]
5. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction. Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112 [TBL] [Abstract][Full Text] [Related]
6. Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Covell DG; Wallqvist A; Huang R; Thanki N; Rabow AA; Lu XJ Proteins; 2005 May; 59(3):403-33. PubMed ID: 15778971 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional adaptation of neuroblastoma cells to hypoxia. Fredlund E; Ovenberger M; Borg K; Påhlman S Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155 [TBL] [Abstract][Full Text] [Related]
8. Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease. Oberthuer A; Warnat P; Kahlert Y; Westermann F; Spitz R; Brors B; Hero B; Eils R; Schwab M; Berthold F; Fischer M Cancer Lett; 2007 Jun; 250(2):250-67. PubMed ID: 17126996 [TBL] [Abstract][Full Text] [Related]
9. [New insights into the genetic basis of neuroblastoma]. Speleman F; De Preter K; Hoebeeck J; Van Roy N; Vandesompele J Verh K Acad Geneeskd Belg; 2007; 69(4):167-96. PubMed ID: 17821957 [TBL] [Abstract][Full Text] [Related]
10. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Winter C; Pawel B; Seiser E; Zhao H; Raabe E; Wang Q; Judkins AR; Attiyeh E; Maris JM Pediatr Blood Cancer; 2008 Jul; 51(1):10-6. PubMed ID: 18213713 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization and classification of neuroblastoma. Oberthuer A; Theissen J; Westermann F; Hero B; Fischer M Future Oncol; 2009 Jun; 5(5):625-39. PubMed ID: 19519203 [TBL] [Abstract][Full Text] [Related]
12. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605 [TBL] [Abstract][Full Text] [Related]
13. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development. Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471 [TBL] [Abstract][Full Text] [Related]
14. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene. Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation. Garcia J; Faca V; Jarzembowski J; Zhang Q; Park J; Hanash S J Proteome Res; 2009 Aug; 8(8):3791-6. PubMed ID: 19505085 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a novel neuroblastoma mouse model. Iwakura H; Ariyasu H; Kanamoto N; Hosoda K; Nakao K; Kangawa K; Akamizu T Int J Oncol; 2008 Dec; 33(6):1195-9. PubMed ID: 19020752 [TBL] [Abstract][Full Text] [Related]
18. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329 [TBL] [Abstract][Full Text] [Related]